Affiliations:
Department of Psychiatry and Psychfapy II Mental Health & Old Age Psychiatry, Ulm University, Ulm, Germany
Correspondence:
[*]
Correspondence to: Karolina Sejunaite, PhD, Division of Mental Health & Old Age Psychiatry, Psychiatry II, Ulm University, Lindenallee 2, D—89312 Günzburg, Germany. Tel.: +49 8221 96 24597; E-mail: karolina.sejunaite@uni-ulm.de.
Abstract: Background: Clock Drawing Test (CDT) is a commonly used screening tool for cognitive disorders, known for its ease of administration and scoring. Despite frequent use by clinicians, CDT is criticized for its poor predictive value in mild cases of impairment. Objective: To evaluate CDT as a screening tool for early stage of cognitive impairment in biomarker-verified Alzheimer’s disease (AD) and depressive disorder (DD). Methods: We analyzed CDT of 172 patients with verified AD, 70 patients with DD, in whom neurodegenerative disorder was excluded using cerebrospinal fluid biomarkers, and 58 healthy older adults. CDT was scored using the semi-quantitative (Shulman) and itemized criteria (adapted from Mendez). Results: Logistic regression showed that for both DD and AD patients with high Mini-Mental State Examination (MMSE) scores (27 and above) the significant predicting variable is uneven number spacing. As MMSE deteriorates (24-26 points), an additional error of setting clock hands is predictive of the disease. In the low MMSE condition, CDT showed an acceptable discrimination for AD (AUC itemized 0.740, Shulman 0.741) and DD (AUC itemized 0.827, Shulman 0.739) using both scoring methods. In the high MMSE condition, discrimination rates were acceptable using itemized scoring but poor using Shulman scoring for both AD (AUC itemized 0.707, Shulman 0.677) and DD (AUC itemized 0.755, Shulman 0.667) groups. Conclusion: Ideally, modern diagnostic process should take place before the cognitive performance drops beneath the healthy range. This makes CDT of little use when screening patients with very mild cognitive deficits.
Keywords: Alzheimer’s disease, dementia, depressive disorder, mental status and
dementia tests, screening
